2010
DOI: 10.5732/cjc.009.10404
|View full text |Cite
|
Sign up to set email alerts
|

CXCR7 in tumorigenesis and progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
16
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 27 publications
3
16
0
Order By: Relevance
“…Interestingly, down-regulation of Lipocalin2 (LCN2), a marker for kidney injury (Viau et al, 2010), implicated in kidney epithelial cell morphogenesis (Gwira et al, 2005) and previously shown to be dysregulated in Apc Min/+ intestinal adenomas (Reichling et al, 2005), was observed in the APC shRNA MDCK cells. Other dysregulated genes including the alpha 1 subunit of type IV collagen (COL4A1, a basement membrane component), C-X-C chemokine receptor type 7 (CXCR7), and ADAM metallopeptidase with thrombospondin type 1, motif 6 (ADAMTS6), are implicated in controlling cell-cell or cell-matrix interactions (Kuhn, 1995; Bevitt et al, 2005; Hou et al, 2010; Aikio et al, 2012). These data collectively support a model in which APC loss-of-function in epithelial cells (through mutation and deletion of its c-terminus or gene silencing) leads to loss of polarity and tissue architecture, and subsequent tumor initiation, via altered communication between neighboring cells and the substratum.…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, down-regulation of Lipocalin2 (LCN2), a marker for kidney injury (Viau et al, 2010), implicated in kidney epithelial cell morphogenesis (Gwira et al, 2005) and previously shown to be dysregulated in Apc Min/+ intestinal adenomas (Reichling et al, 2005), was observed in the APC shRNA MDCK cells. Other dysregulated genes including the alpha 1 subunit of type IV collagen (COL4A1, a basement membrane component), C-X-C chemokine receptor type 7 (CXCR7), and ADAM metallopeptidase with thrombospondin type 1, motif 6 (ADAMTS6), are implicated in controlling cell-cell or cell-matrix interactions (Kuhn, 1995; Bevitt et al, 2005; Hou et al, 2010; Aikio et al, 2012). These data collectively support a model in which APC loss-of-function in epithelial cells (through mutation and deletion of its c-terminus or gene silencing) leads to loss of polarity and tissue architecture, and subsequent tumor initiation, via altered communication between neighboring cells and the substratum.…”
Section: Resultsmentioning
confidence: 99%
“…Depending on the origin of cancer, CXCR7 was described to be expressed both by the tumour cells and the stromal cells (Hou et al , 2010; Sun et al , 2010). Little is known about the protein expression of CXCR7 in CRC.…”
Section: Resultsmentioning
confidence: 99%
“…The CXCR7/CXCR7 ligands axis might be directly implicated in the tumour angiogenesis but also indirectly, by regulating processes that lead up to the expression of proangiogenic factors such as CXCL8 and VEGF (Wang et al , 2008; Hou et al , 2010). Therefore, we assessed the mRNA expression of CXCL8 and VEGF in HT29-injected mice treated (or not) with a CXCR7 antagonist.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The role of CXCR7 has been identified by studies in malignant cells of various tumor types, including breast, lung, prostate and colorectal cancer, highlighting the role of CXCR7 in cancer growth, survival, adhesion, invasion and metastasis [19]. Miao et al [10] showed that CXCR7 promotes the tumor growth of breast and lung cancer cells and lung metastases in both immunodeficient and immunocompetent mouse models.…”
Section: Discussionmentioning
confidence: 99%